Fundraising Fox
DarioHealth
NASDAQ: DRIONew York, US · Founded 2011 · Delaware corporation · 248 employees on LinkedIn · 4 known investors
Find your way into DarioHealth
Sign up to see every warm intro you have to DarioHealth
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DarioHealth team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits. Its platform focuses on day-to-day health management for individuals with one or more chronic conditions, primarily in the U.S.
Founders & leadership
DarioHealth was founded in 2011 by Oren Fuerst, PhD.
OF
Oren Fuerst, PhDFounder
ER
Erez RaphaelCEOErez Raphael is Chief Executive Officer of DarioHealth Corp., a digital health company that provides tools and coaching for chronic disease management.
ZB
Zvi Ben DavidAdvisory BoardHe brings experience as a senior financial executive at public companies listed on NASDAQ and the Tel-Aviv Stock Exchange, with background in fundraising, financial management under IFRS and US GAAP, and scaling organizations from early-stage to multinational operations.
Board
AK
Adam K. SternBoard director
HK
PK
Peter KashBoard director
YS
Yoav ShakedChairman of the Board
JK
DM
Dennis MatheisBoard director
DM
Dennis M. McGrathBoard director
Investors · 4
Agate Medical Investments LPlisted by Agate Medical Investments LPTel-Aviv
How we know: Agate Medical Investments LP's portfolio page · Not right? Tell us
OrbiMedreportedNew York · $1M – $75M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$282.3M disclosed across 19 rounds · 2014–2025
▶$17.5MraisedOct 2025 · 10 investors · Other TechnologyRule 506(b)
▶$17.5MraisedOct 2025 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Lawrence LeisureDirector
- Dennis MatheisDirector
- Steven NelsonExecutive Officer
- Dennis M. McGrathDirector
- Adam K. SternDirector
- Yoav ShakedDirector
- Erez RaphaelExecutive Officer
- Chen Franco-YehudaExecutive Officer, Director
- Hila KarahDirector
- Offering amount
- $17.5M
- Amount sold
- $17.5M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.8MraisedJan 2025 · 18 investors · Other TechnologyRule 506(b)
▶$6.8MraisedJan 2025 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yoav ShakedDirector
- Erez RaphaelExecutive Officer, Director
- Zvi Ben DavidExecutive Officer
- Adam K. SternDirector
- Jon KaplanDirector
- Dennis MatheisDirector
- Dennis M. McGrathDirector
- Steven NelsonExecutive Officer
- Hila KarahDirector
- Offering amount
- $6.8M
- Amount sold
- $6.8M
- Minimum investment
- $1K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.8MraisedJan 2025 · 29 investors · Other TechnologyRule 506(b)
▶$18.8MraisedJan 2025 · 29 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yoav ShakedDirector
- Adam K. SternDirector
- Zvi Ben DavidExecutive Officer
- Dennis MatheisDirector
- Steven NelsonExecutive Officer
- Erez RaphaelExecutive Officer, Director
- Hila KarahDirector
- Dennis M. McGrathDirector
- Jon KaplanDirector
- Offering amount
- $18.8M
- Amount sold
- $18.8M
- Minimum investment
- $1K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.4MraisedFeb 2024 · 119 investors · Other TechnologyRule 506(b)
▶$22.4MraisedFeb 2024 · 119 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Raphael ErezExecutive Officer, Director
- Dennis M. McGrathDirector
- Yoav ShakedExecutive Officer
- Zvi Ben-DavidExecutive Officer
- Richard AndersonExecutive Officer
- Adam SternDirector
- Jon KaplanDirector
- Hila KarahDirector
- Dennis MatheisDirector
- Offering amount
- $22.4M
- Amount sold
- $22.4M
- Sales commissions
- $1.4M
- Placement agents
- Aegis Capital Corp.
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.4MraisedMay 2023 · 18 investors · Other TechnologyRule 506(b)
▶$15.4MraisedMay 2023 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard AndersonExecutive Officer
- Zvi Ben-DavidExecutive Officer
- Raphael ErezExecutive Officer, Director
- Dennis M. McGrathDirector
- Dennis MatthesisDirector
- Adam SternDirector
- Jon KaplanDirector
- Hila KarahDirector
- Yoav ShakedExecutive Officer
- Offering amount
- $15.4M
- Amount sold
- $15.4M
- Finders' fees
- $410K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24MraisedJun 2021 · 74 investors · BiotechnologyRule 506(b)
▶$24MraisedJun 2021 · 74 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erez RaphaelExecutive Officer, Director
- Dennis MatheisDirector
- Yoav ShakedDirector
- Dror BacherExecutive Officer
- Dennis M. McGrathDirector
- Hila KarahDirector
- Zvi Ben-DavidExecutive Officer
- Richard B StoneDirector
- Richard AndersonExecutive Officer
- Adam SternDirector
- Offering amount
- $24M
- Amount sold
- $24M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$31MraisedFeb 2021 · 30 investors · BiotechnologyRule 506(b)
▶$31MraisedFeb 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hila KarahDirector
- Dennis MatheisDirector
- Adam SternDirector
- Yoav ShakedDirector
- Richard AndersonExecutive Officer
- Oded CohenExecutive Officer
- Dror BacherExecutive Officer
- Erez RaphaelExecutive Officer, Director
- Zvi Ben-DavidExecutive Officer
- Richard B StoneDirector
- Adam SternDirector
- Dennis M. McGrathDirector
- Offering amount
- $31M
- Amount sold
- $31M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$70MraisedFeb 2021 · 34 investors · BiotechnologyRule 506(b)
▶$70MraisedFeb 2021 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erez RaphaelExecutive Officer, Director
- Zvi Ben-DavidExecutive Officer
- Dror BacherExecutive Officer
- Richard AndersonExecutive Officer
- Yoav ShakedDirector
- Richard B StoneDirector
- Dennis MatheisDirector
- Hila KarahDirector
- Adam SternDirector
- Dennis M. McGrathDirector
- Adam SternDirector
- Offering amount
- $70M
- Amount sold
- $70M
- Minimum investment
- $100K
- Sales commissions
- $4.9M
- Placement agents
- Stifel, Nicolaus & Company, Incorporated, SternAegis Ventures, Cowen and Company, LLC
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as DarioHealth.
Frequently asked questions
- What does DarioHealth do?
- Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits. Its platform focuses on day-to-day health management for individuals with one or more chronic conditions, primarily in the U.S.
- Who founded DarioHealth?
- DarioHealth was founded by Oren Fuerst, PhD in 2011.
- Who are DarioHealth's investors?
- DarioHealth's investors include Agate Medical Investments LP, Leo Capital Ventures, OrbiMed, Pitango.
- How much funding has DarioHealth raised?
- DarioHealth has disclosed $282.3M raised across 19 rounds.
- Where is DarioHealth headquartered?
- DarioHealth is headquartered in New York, US.